Peter Jensen, MD

Professor and Chair of the Department of Pathology, University of Utah School of Medicine

Education

• Medical Degree—Vanderbilt University
• Internship—Pathology, Barnes-Jewish Hospital
• Residency—Pathology, Barnes-Jewish Hospital

Certification/Affiliations

• American Board of Pathology
• President-Elect, President, Past-President, Association of Pathology Chairs
• Chairman, Board of Directors, ARUP Laboratories
• Chair, AAI Committee on Public Affairs
• APC Exploratory Development Committee
• APC Research Committee

Research Interests

• Healthcare transformation
• Precision diagnostics
• Application of new technology in pathology and laboratory medicine
• Antigen processing and presentation
• MHC molecules in regulating immune responses
• Type 1 diabetes/autoimmunity
• Cancer immunotherapy

Awards

• Summa Cum Laude, 1977
• Elected to American Society for Clinical Investigation, 1996
• Deans Clinical Investigator Award, 2000, 2002
• NIH MERIT Award, 2001
• CAP President’s Honors Award, 2011
• Distinguished Fellow of the American Association of Immunologists, 2020

Recent Publications

• Ghosh D, et al. Regulation of the BCR signalosome by the class II peptide editor, H2-M, affects the development and repertoire of innate-like B cells. Cell Rep. 2022;38(4):110200.
• Bailey DN, et al. Generating discretionary income in an academic department of pathology. Acad Pathol. 2021;8:23742895211044811.
• Kim H, et al. Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes. J Exp Med. 2021;218(3):e20200533.
• Reyes-Vargas E, et al. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft. J Biol Chem. 2020;295(10):2959–73.
• Xiao H, et al. Elimination of osteosarcoma by necroptosis with graphene oxide-associated anti-HER2 antibodies. Int J Mol Sci. 2019;20(18):4360.
• Zhou Z, et al. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing. Eur J Immunol. 2017;47:314–26.